In 1984 was created QUBIS, which is appeared as Corporate Investor. The fund was located in Europe if to be more exact in United Kingdom. The leading representative office of defined Corporate Investor is situated in the Belfast.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars. Considering the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2006. Opposing the other organizations, this QUBIS works on 1 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2010.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight MOF Technologies, Cirdan, Axis Three. Among the most successful fund investment fields, there are Health Diagnostics, Software. The fund has specific favorite in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the QUBIS, startups are often financed by Invest Northern Ireland, EASME - EU Executive Agency for SMEs, Crescent Capital. The meaningful sponsors for the fund in investment in the same round are Co-FundNI, Clarendon Fund Managers, Techstart Ventures. In the next rounds fund is usually obtained by Siemens Technology Accelerator, Johnson Matthey, Invest Northern Ireland.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AARP | District of Columbia, United States, Washington |
| Aventrock Ventures | Alberta, Calgary, Canada |
| Base Case Capital | California, San Francisco, United States |
| Beijing Wenhua Haihui | Beijing, Beijing, China |
| Beiqing Ruichuang | Beijing, Beijing Shi, China |
| BOCGI Zheshang Capital | China, Hangzhou, Zhejiang |
| Central Exchange | China, Hong Kong, Hong Kong Island |
| Cooley | California, Palo Alto, United States |
| Essence VC | - |
| EuroFinLeading Private Equity | - |
| Hunan Zhongai Social Impact Investment | China, Fujian, Hunan |
| Impres Health | - |
| K2 Investment Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
| Lauder Partners | Atherton, California, United States |
| MPM Bio IV NVS Strategic Fund | - |
| Prudence Venture Investment Corporation | - |
| Suzhou Haihui Jijin | China, Jiangsu, Suzhou |
| Whole Foods Market | Austin, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GenoMe Diagnostics | $1M | 03 Mar 2023 | Belfast, Northern Ireland, United Kingdom | ||
Re-Vana Therapeutics | $13M | 30 Nov 2022 | Belfast, Northern Ireland, United Kingdom | ||
VascVersa | $685K | 08 Aug 2022 | Belfast, Northern Ireland, United Kingdom | ||
Sonrai Analytics | $2M | 21 Jun 2022 | Belfast, Northern Ireland, United Kingdom | ||
Aramune Technologies | $1M | 25 May 2022 | Belfast, Northern Ireland, United Kingdom | ||
Univ8 Genomics | 01 Jan 2022 | Belfast, Northern Ireland, United Kingdom | |||
AntennaWare | 08 Jun 2021 | Belfast, Northern Ireland, United Kingdom | |||
GenoMe Diagnostics | $411K | 25 May 2021 | Belfast, Northern Ireland, United Kingdom | ||
| 17 May 2021 | Belfast, Northern Ireland, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GenoMe Diagnostics | $1M | 03 Mar 2023 | Belfast, Northern Ireland, United Kingdom | ||
Re-Vana Therapeutics | $13M | 30 Nov 2022 | Belfast, Northern Ireland, United Kingdom | ||
VascVersa | $685K | 08 Aug 2022 | Belfast, Northern Ireland, United Kingdom | ||
Sonrai Analytics | $2M | 21 Jun 2022 | Belfast, Northern Ireland, United Kingdom | ||
Aramune Technologies | $1M | 25 May 2022 | Belfast, Northern Ireland, United Kingdom | ||
Univ8 Genomics | 01 Jan 2022 | Belfast, Northern Ireland, United Kingdom | |||
AntennaWare | 08 Jun 2021 | Belfast, Northern Ireland, United Kingdom | |||
GenoMe Diagnostics | $411K | 25 May 2021 | Belfast, Northern Ireland, United Kingdom | ||
| 17 May 2021 | Belfast, Northern Ireland, United Kingdom |
